← Stocks · ACON record
Signal record & history · Trifecta Signals
Aclarion, has been flagged by the Trifecta screener 2 times since 2024. 2 signals confirmed; the median confirmed signal is down 99.6% since its Early Signal.
Price refreshes every trading day after the close.
Full interactive chart ↗ · partner link
Daily closes · through the most recent close
Price history from Jan 2018 · Signal tracking began Jan 2022
Headline statistics: confirmed signals only, measured from the confirmation price.
First signal Feb 2024 · Latest Jan 2025 · Confirmed 2 of 2 Early · Latest close in the chart data: Thu, Nov 5, 2026
Groups are mutually exclusive — every confirmed signal sits in exactly one.
Since February 2024, Aclarion has had two Early signals, two confirmed. Zero of the two decided signals gained +10% within 90 days, and zero of two finished ahead of the S&P 500 since confirmation. Two signals carried a caution flag.
Every Early signal in the record, newest first.
Members see every signal below, and the group mix above.
Membership unlocks the complete signal timeline for ACON and every other stock in the record — group tags, caution flags, and the full screener.
Already a member? Sign in and this page unlocks.
Classified in the Healthcare sector and the Diagnostics & Research industry, Aclarion trades under the ACON ticker. With a market value of about $5.1 million, the company falls in the small-cap group.
One run stands out on the record: a confirmation in February 2024 was followed by a fall of about 84% over the next 90 days. Aclarion’s February 2025 signal, which landed in the Downtrend group, fell about 95% over the following 90 days. On classification, revenue was shrinking by about 41% at the time, and it sat in the mid-cap group when that signal fired.
The stock closed Thursday, November 5 at $1.55, down 10.9% on the day. Recent trading has kept the shares between about $1.55 and $1.95 over the past week.